Financials Immunovia AB London S.E.

Stocks

Market Closed - London S.E. Other stock markets 10:45:34 2025-11-03 EST			5-day change	1st Jan Change
31.92 ^SEK	-32.03%		+16,507.70%	+13,658.62%

06-15	Immunovia Unveils New Data Ahead of Medicare Reimbursement Application	FW
06-15	Immunovia Announces New Performance Data for PancreaSure Ahead of Upcoming Application for Medicare Coverage	CI

Fiscal Period: December	2021	2022	2024	2025	2026	2027	2028
Net sales ¹	0.956	1.204	-	0.752	3.2	17.3	55
Change	-	25.94%	-	-	325.53%	440.62%	217.92%
EBITDA ¹	-147.6	-166.2	-	-78.06	-89	-80	-47
Change	-	-12.65%	-	-	-14.01%	10.11%	41.25%
EBIT ¹	-166.6	-191.2	-	-80.38	-91	-82	-50
Change	-	-14.72%	-	-	-13.21%	9.89%	39.02%
Interest Paid	-	-	-	-65.53	-	-	-
Earnings before Tax (EBT) ¹	-156	-168.1	-	-145.9	-91	-82	-50
Change	-	-7.77%	-	-	37.63%	9.89%	39.02%
Net income ¹	-156	-168.1	-76.54	-145.9	-91	-82	-50
Change	-	-7.77%	-	-90.64%	37.63%	9.89%	39.02%
Announcement Date	2/17/22	2/23/23	2/25/25	2/24/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021 Q2	2021 Q3	2021 Q4	2022 Q2	2022 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1
Net sales ¹	-	0.386	0.344	0.108	0.381	-	0.201	0.096	0.101	0.354	0.424	-	1	2	4
Change	-	-	-10.88%	-68.6%	252.78%	-	-	-52.24%	5.21%	250.5%	19.77%	-	-	100%	100%
EBITDA ¹	-	-33.72	-44.68	-44.45	-35.78	-	-18.03	-19.73	-24.6	-15.7	-18.42	-24	-26	-20	-19
Change	-	-	-32.51%	0.53%	19.5%	-	-	-9.45%	-24.69%	36.17%	-17.29%	-30.31%	-8.33%	23.08%	5%
EBIT ¹	-	-39.94	-50.88	-50.79	-41.92	-	-18.91	-20.05	-25.02	-16.38	-18.43	-25	-26	-21	-20
Change	-	-	-27.39%	0.18%	17.47%	-	-	-6.06%	-24.78%	34.55%	-12.57%	-35.62%	-4%	19.23%	4.76%
Charge d'intérêts	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	-	-36.13	-47.13	-33.73	-22.93	-	-57.79	-41.05	-29.74	-17.33	-18.43	-25	-26	-21	-20
Change	-	-	-30.44%	28.44%	32%	-	-	28.97%	27.54%	41.75%	-6.39%	-35.62%	-4%	19.23%	4.76%
Net income ¹	-49.26	-36.13	-47.13	-33.73	-22.93	3.07	-57.79	-41.05	-29.74	-17.33	-18.43	-25	-26	-21	-20
Change	-	26.65%	-30.44%	28.44%	32%	113.39%	-1,982.48%	28.97%	27.54%	41.75%	-6.39%	-35.62%	-4%	19.23%	4.76%
Announcement Date	8/19/21	11/11/21	2/17/22	8/24/22	11/10/22	2/25/25	5/14/25	8/28/25	11/26/25	2/24/26	5/7/26	-	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2024	2025	2026	2027	2028
Net Debt ¹	-254	-68.5	-	-76.6	-67	-74	-18
Change	-	73.03%	-	-	12.53%	-10.45%	75.68%
Announcement Date	2/17/22	2/23/23	2/25/25	2/24/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2025	2026	2027	2028
CAPEX ¹	24.18	1.624	-	-	-	-
Change	-	-93.28%	-	-	-	-
Free Cash Flow (FCF) ¹	-155.8	-177.2	-83.96	-94	-87	-56
Change	-	-13.78%	-	-11.96%	7.45%	35.63%
Announcement Date	2/17/22	2/23/23	2/24/26	-	-	-

¹SEK in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-15,435.67%	-13,807.06%	-	-	-10,380.32%	-2,781.25%	-462.43%	-85.45%
EBIT Margin (%)	-17,429.71%	-15,876.25%	-	-	-10,689.49%	-2,843.75%	-473.99%	-90.91%
EBT Margin (%)	-16,314.44%	-13,961.13%	-	-	-19,403.59%	-2,843.75%	-473.99%	-90.91%
Net margin (%)	-16,314.44%	-13,961.13%	-	-	-19,403.59%	-2,843.75%	-473.99%	-90.91%
FCF margin (%)	-16,291.84%	-14,718.11%	-	-	-11,164.76%	-2,937.5%	-502.89%	-101.82%
FCF / Net Income (%)	99.86%	105.42%	-	-	57.54%	103.3%	106.1%	112%
Profitability
ROA	-	-	-	-	-240.68%	-110%	-100%	-76%
ROE	-30.19%	-	-	-	-382.06%	-147%	-127%	-110%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	2,529.71%	134.88%	-	-	-	-	-	-
CAPEX / EBITDA (%)	-16.39%	-0.98%	-	-	-	-	-	-
CAPEX / FCF (%)	-15.53%	-0.92%	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-781	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	1,917	1,077	-	-	-	-	-	-
Change	-	-43.82%	-	-	-	-	-	-
EPS ¹	-689	-743	-	-93	-0.42	-0.1	-0.04	-0.02
Change	-	-7.84%	-	-	99.55%	76.19%	60%	50%
Nbr of stocks (in thousands)	22,632	22,632	-	169,711	672,667	672,667	672,667	672,667
Announcement Date	2/17/22	2/23/23	-	2/25/25	2/24/26	-	-	-